Drugs / ON-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06562621 | Aug 2018 → Aug 2022 | glioblastoma | Beijing Neurosurgical Institute | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ON-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06562621 ↗ |
| Route | Other | “1ml intratumoral injection of ON-01” NCT06562621 ↗ |